Old Port Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM
Old Port Advisors's ALXN Position: Q3 2021 in Review
Old Port Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,125 shares — an estimated $210K sold.
Old Port Advisors first reported a position in ALXN in Q2 2020 and held it in 4 quarters. The position peaked at $219K in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.
- Old Port Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Old Port Advisors sold 1,125 Alexion Pharmaceuticals shares in Q3 2021, an estimated $210K.
- Old Port Advisors first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 4 quarters.
- Old Port Advisors's Alexion Pharmaceuticals position peaked at $219K in Q3 2020.
- 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.
Based on Old Port Advisors's 13F filing for Q3 2021, filed 12 Oct 2021.